Uveitis Withdrawn Phase 3 Trials for Secukinumab (DB09029)

Also known as: Unspecified iridocyclitis / Uveitis NOS / Uveitis (disorder)

IndicationStatusPhase
DBCOND0009937 (Uveitis)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT01327664Study to Evaluate the Long Term Use of Treatment With AIN457 for UveitisTreatment
NCT01103024Extension Study to Assess Safety and Efficacy of AIN457 in Patients With Active Non-infectious UveitisTreatment